as of 09-28-2026 4:00pm EST
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.
| Founded: | 2013 | Country: | Taiwan |
| Employees: | N/A | City: | N/A |
| Market Cap: | 543.0M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 701.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $1.70 - $22.00 | Next Earning Date: | 05-12-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
CEO
Avg Cost/Share
$3.93
Shares
3,100
Total Value
$12,183.00
Owned After
11,245,631
SEC Form 4
CEO
Avg Cost/Share
$3.67
Shares
18,378
Total Value
$67,447.26
Owned After
11,245,631
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Shen Ethan PhD | YDES | CEO | Sep 9, 2026 | Buy | $3.93 | 3,100 | $12,183.00 | 11,245,631 | |
| Shen Ethan PhD | YDES | CEO | Sep 4, 2026 | Buy | $3.67 | 18,378 | $67,447.26 | 11,245,631 |
See how YDES stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "YDES YD Bio Limited Ordinary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.